Generics: The Game Changer in Affordable Healthcare

By: Hridkamal Roy, Assistant Managing Editor, India Pharma Outlook

A strip of Lipitor (branded drug) costs more than 800 INR and Atorvastatin (Lipitor’s generic version) costs within 72 INR. Many other such examples can be given where a branded medicine costs 10-12 times more than its generic version

Efficient Solutions for Medicines Distribution in the Digital Age

By: Janifha Evangeline, Assistant Editor, India Pharma Outlook

The medicine distribution business is huge and the pharmaceutical distribution companies/Pharma distributors play a major role in the pharmaceutical sector when it comes to medicines distribution

Key Considerations When Choosing a Pharmaceutical Consulting Firm

By: Hridkamal Roy, Assistant Managing Editor, India Pharma Outlook

It is the duty of pharmaceutical consultants to provide services all along a product lifecycle that includes processes like planning, design and construction, commissioning and testing of products.

Building Pharma Teams: Embracing Skill-Based Recruitment

By: Hridkamal Roy, Assistant Managing Editor, India Pharma Outlook

Skill-based hiring is gaining momentum in the pharmaceutical market with advancing technologies, shift in patient demographics and changing medical practices.

How India is Revolutionizing Drug Production with Greenfield Parks

By: Rejith P R, Correspondent, India Pharma Outlook

Dr. Mansukh Mandaviya, Union Minister for Chemicals & Fertilizers, inaugurated 27 greenfield bulk drug park projects and 13 greenfield manufacturing plants for medical devices, last week. He pointed out the significance of medicine in society...

Cutting-Edge Extraction Methods Shaping the Herbal Extract Industry

By: Hridkamal Roy, Assistant Managing Editor, India Pharma Outlook

Usage of herbal extracts for pharmaceutical formulations have grown over the years and that has contributed to the estimated growth of the industry for plant extracts to 61.5 Bn USD by 2027 exhibiting a CAGR of 12.2 percent

© 2024 India Pharma Outlook. All Rights Reserved.